Atrial Fibrillation Characteristics in Patients on Haemodialysis vs. Peritoneal Dialysis

被引:11
作者
Abuhasira, Ran [1 ,2 ]
Mizrakli, Yuval [1 ,2 ]
Shimony, Avi [3 ,5 ]
Novack, Victor [2 ,5 ]
Shnaider, Alla [4 ,5 ]
Haviv, Yosef S. [4 ,5 ]
机构
[1] Ben Gurion Univ Negev, Fac Hlth Sci, Joyce & Irving Goldman Med Sch, Beer Sheva, Israel
[2] Soroka Univ, Med Ctr, Clin Res Ctr, Beer Sheva, Israel
[3] Soroka Univ, Med Ctr, Dept Cardiol, Beer Sheva, Israel
[4] Soroka Univ, Med Ctr, Dept Nephrol, Beer Sheva, Israel
[5] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel
来源
SCIENTIFIC REPORTS | 2018年 / 8卷
关键词
STAGE RENAL-DISEASE; RISK-FACTORS; STROKE; INSIGHTS; WARFARIN;
D O I
10.1038/s41598-018-21229-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Atrial fibrillation (AF) is highly prevalent in dialysis patients, however whether its impact differs between patients on haemodialysis (HD) vs. peritoneal dialysis (PD) is unknown. We aimed to compare the association of AF and clinical outcomes in different dialysis modalities. We performed a population based retrospective cohort study, including adult patients who initiated dialysis between the years 2002 and 2015. Clinical, echocardiographic and laboratory data were reviewed and correlated with outcomes in HD vs. PD. During the study period, 1,130 patients began dialysis. Of the 997 patients without AF before dialysis initiation, 17% developed new-onset AF after the initiation of dialysis (17.3% of HD vs. 13.7% of PD patients, p = 0.27). Using multivariate analysis, only enlarged left atrium at dialysis initiation (hazard ratio (HR) 2.82, CI95% 2.00-3.99) and age (HR 1.04, CI95% 1.03-1.06) were significantly associated with AF. Dialysis modality was not a significant predictor of AF in either univariate or multivariate analysis. In conclusion, our study demonstrated that AF is common in dialysis patients irrespective of modality. In our cohort, the risk factors associated with AF were older age and enlarged left atrium. AF was associated with increased rates of heart failure and mortality, but not stroke.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and heart failure
    Martinez, Brandon K.
    Bunz, Thomas J.
    Eriksson, Daniel
    Meinecke, Anna-Katharina
    Sood, Nitesh A.
    Coleman, Craig I.
    ESC HEART FAILURE, 2019, 6 (01): : 10 - 15
  • [22] Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation
    Hendriks, Jeroen M. L.
    de Wit, Rianne
    Crijns, Harry J. G. M.
    Vrijhoef, Hubertus J. M.
    Prins, Martin H.
    Pisters, Ron
    Pison, Laurent A. F. G.
    Blaauw, Yuri
    Tieleman, Robert G.
    EUROPEAN HEART JOURNAL, 2012, 33 (21) : 2692 - 2699
  • [23] Is anticoagulating haemodialysis patients with non-valvular atrial fibrillation too risky?
    Parker, Kathrine
    Mitra, Sandip
    Thachil, Jecko
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (06) : 725 - 736
  • [24] Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation
    Dorian, Paul
    Kongnakorn, Thitima
    Phatak, Hemant
    Rublee, Dale A.
    Kuznik, Andreas
    Lanitis, Tereza
    Liu, Larry Z.
    Iloeje, Uchenna
    Hernandez, Luis
    Lip, Gregory Y. H.
    EUROPEAN HEART JOURNAL, 2014, 35 (28) : 1897 - 1906
  • [25] Comparison of outcome and quality of life: haemodialysis versus peritoneal dialysis patients
    Noshad, H.
    Sadreddini, S.
    Nezami, N.
    Salekzamani, Y.
    Ardalan, M. R.
    SINGAPORE MEDICAL JOURNAL, 2009, 50 (02) : 185 - 192
  • [26] Peritoneal dialysis versus haemodialysis for people commencing dialysis (Review)
    Ethier, Isabelle
    Hayat, Ashik
    Pei, Juan
    Hawley, Carmel M.
    Johnson, David W.
    Francis, Ross S.
    Wong, Germaine
    Craig, Jonathan C.
    Viecelli, Andrea K.
    Cho, Yeoungjee
    Htay, Htay
    Ng, Samantha
    Leibowitz, Saskia
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (06):
  • [27] Initiation of Dabigatran vs. Warfarin in Anticoagulant Naive Atrial Fibrillation Patients: A Nationwide Study
    Olesen, Jonas B.
    Gislason, Gunnar H.
    Torp-Pedersen, Christian
    Fosbol, Emil L.
    CIRCULATION, 2013, 128 (22)
  • [28] Anticoagulation management in haemodialysis patients with atrial fibrillation: evidence and opinion
    De Vriese, An S.
    Heine, Gunnar
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (11) : 2072 - 2079
  • [29] Atrial Fibrillation in Patients with End-stage Kidney Disease on Dialysis
    Watanabe, Hiroshi
    Minamino, Tohru
    INTERNAL MEDICINE, 2018, 57 (16) : 2285 - 2286
  • [30] Edoxaban vs. Warfarin in East Asian Patients With Atrial Fibrillation - An ENGAGE AF-TIMI 48 Subanalysis -
    Yamashita, Takeshi
    Koretsune, Yukihiro
    Yang, Yuejin
    Chen, Shih-Ann
    Chung, Namsik
    Shimada, Yuichi J.
    Kimura, Tetsuya
    Miyazaki, Koichi
    Abe, Kenji
    Mercuri, Michele
    Ruff, Christian T.
    Giugliano, Robert P.
    CIRCULATION JOURNAL, 2016, 80 (04) : 860 - +